Hyperlipidemia

Hyperlipidemia is a metabolic disorder characterized by abnormally elevated systemic concentrations of lipids or lipoproteins, including low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides

Hyperlipidemia is a metabolic disorder characterized by abnormally elevated systemic concentrations of lipids or lipoproteins, including low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides

Primarily impacting the cardiovascular and vascular systems across pediatric and adult populations, the condition stems from primary genetic mutations or secondary factors such as obesity, diabetes, and dietary intake

Primarily impacting the cardiovascular and vascular systems across pediatric and adult populations, the condition stems from primary genetic mutations or secondary factors such as obesity, diabetes, and dietary intake

Pathophysiologically, altered lipid synthesis, transport, or clearance leads to the accumulation of atherogenic circulating particles that deposit within the vascular endothelium

Pathophysiologically, altered lipid synthesis, transport, or clearance leads to the accumulation of atherogenic circulating particles that deposit within the vascular endothelium

Pathophysiologically, altered lipid synthesis, transport, or clearance leads to the accumulation of atherogenic circulating particles that deposit within the vascular endothelium

This process accelerates systemic atherogenesis, substantially elevating the long-term clinical risk for coronary artery disease, myocardial infarction, and ischemic stroke

This process accelerates systemic atherogenesis, substantially elevating the long-term clinical risk for coronary artery disease, myocardial infarction, and ischemic stroke

This process accelerates systemic atherogenesis, substantially elevating the long-term clinical risk for coronary artery disease, myocardial infarction, and ischemic stroke